{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-052635","form_type":"8-K","ticker":"ADTX","cik":"0001726711","company_name":"Aditxt, Inc.","filed_at":"2025-06-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.487951+00:00","generated_at":"2026-05-19T17:19:17.452657+00:00","sec_items":["1.01","2.03","3.02","5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Aditxt appoints Evofem CEO Saundra Pelletier to board; officer loans $70K","bullets":["Board appoints Saundra Pelletier (CEO of Evofem) as director, effective June 5, 2025.","Chief Innovation Officer Shahrokh Shabahang loans $70,000 at 7.5%, due Dec 5, 2025.","Weekly update: Adimune targets Q4 2025 regulatory submission for ADI-100 autoimmune therapy.","Evofem generated $20M net revenue in 2024; CEO cites capital dependency for growth.","Pending Evofem merger extended to Sept 30, 2025; capital needed for milestones."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-052635","json":"https://secwatch.observer/filing/0001213900-25-052635.json","markdown":"https://secwatch.observer/filing/0001213900-25-052635.md","text":"https://secwatch.observer/filing/0001213900-25-052635.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1726711/000121390025052635/0001213900-25-052635-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1726711/000121390025052635/ea0245171-8k_aditxt.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T17:19:17.452657+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f06865660e","claim":"Saundra Pelletier was appointed as director at Aditxt, Inc..","evidence_excerpt":"On June 5, 2025, the Board of Directors (the “ Board ”) of the Company, with the recommendation of the Nominating and Corporate Governance Committee, appointed Ms. Saundra Pelletier as a member of the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1726711/000121390025052635/0001213900-25-052635-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}